GoodRx Holdings Inc

GoodRx Holdings Inc (GDRX) Stock Analysis

$3.360

-0.139 (-4.14%)At close

Loading chart…
High
3.495
Open
3.480
VWAP
3.40
Volume
848.20K
Mkt Cap
2.89B
Low
3.330
Amount
2.88M
EV/EBITDA, TTM
7.46

GoodRx Holdings, Inc. is a platform for medication savings in the United States, used by consumers and healthcare professionals. The Company connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The Company's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The Company partners with pharma manufacturers to advertise and integrate their affordable solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.

AI analysis of GoodRx Holdings Inc (GDRX)

Buy

GoodRx Holdings Inc is a good buy right now due to its current price of $3.43, which is below the average analyst target price of $4.50. The stock has shown a positive trend with a 5-day change of +4.57% and a year-to-date change of +24.73%. However, the main risk is the declining net income, which dropped to $1.17 million in Q1 2026 from $12.84 million in Q2 2025, indicating potential profitability issues.

Valuation Metrics

The current forward P/E ratio for GoodRx Holdings Inc (GDRX) is 10.29, compared to its 5-year average forward P/E of 36.79.

Forward P/E

Fair
5Y Average P/E
36.79
Current P/E
10.29
Overvalued
645.32
Undervalued
-571.73

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
13.01
Current EV/EBITDA
7.46
Overvalued
25.27
Undervalued
0.75

Forward P/S

Fair
5Y Average P/S
3.65
Current P/S
1.38
Overvalued
7.33
Undervalued
-0.03

Alphio AI Price Scenarios for GDRX

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%GDRX

$4.23

Scenario price

B

Base

Base · 50%GDRX

$3.42

Scenario price

B

Bear

Bear · 25%GDRX

$3.21

Scenario price

Whales holding GDRX

S

Silver Lake Technology Management, L.L.C.

+ HoldingGDRX

+14.72%

3M Return

T

TCMI Inc.

+ HoldingGDRX

+1.93%

3M Return

Events Timeline

2026-09-03 (ET)

09:30:00

GoodRx Launches Family Plan for $24.99 Monthly

2026-08-05 (ET)

17:31:00

GoodRx Q2 Revenue $200.4M, Exceeds Consensus

17:30:00

Raises FY26 Adjusted EBITDA Outlook to $240M-$250M

2026-05-27 (ET)

09:10:00

GoodRx Launches GoodRx Companion Subscription at $14.99 per Month

2026-05-06 (ET)

17:10:00

Raises FY26 Adjusted EBITDA Outlook to Over $235M

News

GDRX FAQ — answered by Alphio AI

GoodRx Holdings, Inc. is a platform for medication savings in the United States, used by consumers and healthcare professionals. The Company connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The Company's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The Company partners with pharma manufacturers to advertise and integrate their affordable solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications. It operates in the Technology sector (SERVICES-COMPUTER PROCESSING & DATA PREPARATION industry).

GoodRx Holdings Inc is a good buy right now due to its current price of $3.43, which is below the average analyst target price of $4.50. The stock has shown a positive trend with a 5-day change of +4.57% and a year-to-date change of +24.73%. However, the main risk is the declining net income, which dropped to $1.17 million in Q1 2026 from $12.84 million in Q2 2025, indicating potential profitability issues.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading